Skip to main content
NCBI home page
Gut logoLink to Gut
. 2001 Mar;48(3):409–413. doi: 10.1136/gut.48.3.409

The causes of obvious jaundice in South West Wales: perceptions versus reality

M Whitehead 1, I Hainsworth 1, J Kingham 1
PMCID: PMC1760136  PMID: 11171834

Abstract

AIMS—(1) A prospective analysis of clinically obvious jaundice (bilirubin >120 µmol/l) in South Wales to determine accuracy of diagnosis, referral pattern, treatment, and outcome. (2) To compare British gastroenterologists' and local general practitioners' perceptions of common causes of jaundice with our study findings.
METHODS—Over a seven month period all patients with bilirubin >120 µmol/l (excluding neonates with physiological jaundice) were identified by a biochemistry laboratory serving three general hospitals and the community. Clinical data were recorded prospectively. Sixty nine consultant gastroenterologists and 67 local general practitioners (GPs) were asked to cite the commonest causes of bilirubin >120 µmol/l in their experience.
RESULTS—A total of 121 patients were identified of whom 95 were admitted to hospital because of jaundice, 22 developed jaundice while in hospital, and four remained in the community. Causes of jaundice were: malignancy 42, sepsis/shock 27, cirrhosis 25, gall stones 16, drugs 7, autoimmune hepatitis 2, and viral hepatitis 2. One in five was wrongly diagnosed, often as viral hepatitis. Although 30% were under surgical care only 4% required surgery. Overall mortality was high (31%) and greatest in sepsis/shock (51%). Gastroenterologists and GPs both perceived malignancy and gall stones to be the commonest causes of marked jaundice followed by viral hepatitis and cirrhosis; sepsis/shock was hardly mentioned.
CONCLUSIONS—There are important discrepancies between gastroenterologists' and GPs' perceptions of likely causes of jaundice and the actual causes we have shown. In particular, sepsis/shock is common in hospital practice but is overlooked whereas viral hepatitis is rare but perceived as common and overdiagnosed. Gall stones usually cause mild jaundice with bilirubin levels less than 120 µmol/l. Many patients are referred to surgical services for historical reasons yet rarely require surgery and are usually treated by physicians or endoscopists.


Keywords: jaundice; bilirubin; sepsis; hepatitis; gall stones; questionnaire

Full Text

The Full Text of this article is available as a PDF (119.9 KB).

Figure 1  .

Figure 1  

Open in a new tab

Causes of jaundice in the 121 patients identified.

Figure 2  .

Figure 2  

Open in a new tab

Peak bilirubin levels for each diagnostic group (with medians).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aithal G. P., Rawlins M. D., Day C. P. Accuracy of hepatic adverse drug reaction reporting in one English health region. BMJ. 1999 Dec 11;319(7224):1541–1541. doi: 10.1136/bmj.319.7224.1541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bach N. The significance of alcoholic liver disease to contemporary clinical hepatology. Hepatology. 1996 Oct;24(4):959–960. doi: 10.1053/jhep.1996.v24.ajhep0240959. [DOI] [PubMed] [Google Scholar]
  3. Banks J. G., Foulis A. K., Ledingham I. M., Macsween R. N. Liver function in septic shock. J Clin Pathol. 1982 Nov;35(11):1249–1252. doi: 10.1136/jcp.35.11.1249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bjorneboe M., Iversen O., Olsen S. Infective hepatitis and toxic jaundice in a municipal hospital during a five-year period. Incidence and prognosis. Acta Med Scand. 1967 Oct;182(4):491–501. doi: 10.1111/j.0954-6820.1967.tb10873.x. [DOI] [PubMed] [Google Scholar]
  5. Brown A. N., Sheiner L. B., Cohen S. N. Evaluation of bilirubin in a liver screening panel. JAMA. 1992 Sep 23;268(12):1542–1542. [PubMed] [Google Scholar]
  6. Byron D., Minuk G. Y. Clinical hepatology: profile of an urban, hospital-based practice. Hepatology. 1996 Oct;24(4):813–815. doi: 10.1002/hep.510240410. [DOI] [PubMed] [Google Scholar]
  7. Crawford J. M., Boyer J. L. Clinicopathology conferences: inflammation-induced cholestasis. Hepatology. 1998 Jul;28(1):253–260. doi: 10.1002/hep.510280133. [DOI] [PubMed] [Google Scholar]
  8. Franson T. R., Hierholzer W. J., Jr, LaBrecque D. R. Frequency and characteristics of hyperbilirubinemia associated with bacteremia. Rev Infect Dis. 1985 Jan-Feb;7(1):1–9. doi: 10.1093/clinids/7.1.1. [DOI] [PubMed] [Google Scholar]
  9. Jaundice due to bacterial infection. Gastroenterology. 1979 Aug;77(2):362–374. [PubMed] [Google Scholar]
  10. Kingham J. G. Clinical hepatology: alcoholic liver disease, not viral hepatitis, predominates in South Wales. Hepatology. 1997 May;25(5):1297–1297. doi: 10.1002/hep.510250545. [DOI] [PubMed] [Google Scholar]
  11. Ledingham I. M., McArdle C. S. Prospective study of the treatment of septic shock. Lancet. 1978 Jun 3;1(8075):1194–1197. doi: 10.1016/s0140-6736(78)90979-0. [DOI] [PubMed] [Google Scholar]
  12. Malchow-Møller A., Matzen P., Bjerregaard B., Hilden J., Holst-Christensen J., Staehr Johansen T., Altman L., Thomsen C., Juhl E. Causes and characteristics of 500 consecutive cases of jaundice. Scand J Gastroenterol. 1981;16(1):1–6. [PubMed] [Google Scholar]
  13. Moseley R. H. Sepsis and cholestasis. Clin Liver Dis. 1999 Aug;3(3):465–475. doi: 10.1016/s1089-3261(05)70080-5. [DOI] [PubMed] [Google Scholar]
  14. Pearlman F. C., Lee R. T. Detection and measurement of total bilirubin in serum, with use of surfactants as solubilizing agents. Clin Chem. 1974 Apr;20(4):447–453. [PubMed] [Google Scholar]
  15. SCHMID M., HEFTI M. L., GATTIKER R., KISTLER H. J., SENNING A. BENIGN POSTOPERATIVE INTRAHEPATIC CHOLESTASIS. N Engl J Med. 1965 Mar 18;272:545–550. doi: 10.1056/NEJM196503182721101. [DOI] [PubMed] [Google Scholar]
  16. Sikuler E., Guetta V., Keynan A., Neumann L., Schlaeffer F. Abnormalities in bilirubin and liver enzyme levels in adult patients with bacteremia. A prospective study. Arch Intern Med. 1989 Oct;149(10):2246–2248. [PubMed] [Google Scholar]
  17. Stern R. B., Knill-Jones R. P., Williams R. Use of computer program for diagnosing jaundice in district hospitals and specialized liver unit. Br Med J. 1975 Jun 21;2(5972):659–662. doi: 10.1136/bmj.2.5972.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Utili R., Abernathy C. O., Zimmerman H. J. Inhibition of Na+, K+-adenosinetriphosphatase by endotoxin: a possible mechanism for endotoxin-induced cholestasis. J Infect Dis. 1977 Oct;136(4):583–587. doi: 10.1093/infdis/136.4.583. [DOI] [PubMed] [Google Scholar]
  19. Whitehead M. W., Hawkes N. D., Hainsworth I., Kingham J. G. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut. 1999 Jul;45(1):129–133. doi: 10.1136/gut.45.1.129. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES